Promega launches Microsatellite Instability (MSI) educational resource in front of 2019 American Society of Clinical Oncology (ASCO) annual meeting

Madison, WI USA. (May 31, 2019) Oncology researchers and clinicians seeking to deepen their understanding of Microsatellite Instability (MSI) have a new resource that gathers a wealth of information in one place, including the importance of MSI as a biomarker and methods of detection. Promega Corporation launched its MSI educational website Promega.com/MSIweb this week ahead of this weekend’s... Read more

Fluidigm Introduces Automated Advanta Solid Tumor NGS Library Prep Assay Using Microfluidics Technology

The first commercially available targeted NGS assay that enables simultaneous detection of somatic variants across 53 solid tumor genes using a highly efficient microfluidic library prep workflow SOUTH SAN FRANCISCO, Calif., May 29, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today introduced the Advanta™... Read more

World’s First Large-Scale, Automated Microwave Peptide Synthesizer

(Matthews, North Carolina) May 21, 2019 – CEM Corporation is proud to announce the release of the world’s first ever large-scale, automated microwave peptide synthesizer. The system, named Liberty PRO, provides for the unprecedented synthesis of up to 1 kg of crude peptide per batch utilizing reaction vessel sizes up to 15 liters. The Liberty PRO provides unmatched purity, speed,... Read more

New England Biolabs® expands its Monarch Nucleic Acid Purification portfolio with a genomic DNA extraction and purification kit

A comprehensive solution for cell lysis, RNA removal and purification of intact genomic DNA from a wide variety of biological samples, including, but not limited to, cultured cells, blood and mammalian tissues. Ipswich, MA, USA (May 15th, 2019) — New England Biolabs® (NEB®) today announced the release of its Monarch Genomic DNA Purification Kit. The... Read more

Illumina Files Patent Infringement Suit Against BGI in Denmark

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed another patent infringement suit against one of BGI Group’s subsidiaries, BGI Europe A/S. Illumina filed suit in the Maritime & Commercial High Court of Denmark. “As we have previously stated, Illumina will continue to vigorously protect our patented technology and file patent suits... Read more

Thermo Scientific SureTect Real-Time PCR Pathogen Detection System provides an easy-to-use workflow for rapid, accurate pathogen detection

Thermo Scientific SureTect Real-Time PCR Pathogen Detection System provides an easy-to-use workflow for rapid, accurate pathogen detection Extended validation scope means more streamlined rapid pathogen testing for food-testing laboratories BASINGSTOKE, England, May 15, 2019 /PRNewswire/ — Thermo Scientific SureTect PCR Assays are now validated to run on the Applied Biosystems SimpliAmp Thermal Cycler and Applied Biosystems... Read more

New tissue clearing kits and reagents for faster, accurate 3D imaging

New tissue clearing kits and reagents for faster, accurate 3D imagingAbcam’s tissue clearing kits and reagents enable easy and rapid clearing for 3D imaging of tissues and cell culture models. Traditionally, 3D imaging of thick tissue sections and 3D cell culture models (organoids, microtissues, spheroids) has presented many technical challenges, including laborious and time-consuming tissue processing, layer-by-layer... Read more

IDT brings unmatched customization to NGS

May 9, 2019 Launch of Custom NGS Adapters and portfolio expansion delivers unprecedented flexibility and ease-of-use CORALVILLE, IA (May 9, 2019) – Demonstrating its advocacy for genomics research, Integrated DNA Technologies (IDT) announces a significant expansion to its NGS portfolio. The company is excited to launch a unique Custom NGS Adapters offering, becoming the only genomics provider to provide an... Read more

Agilent Announces Unique Portfolio to Advance Immunotherapy

Agilent Announces Unique Portfolio to Advance Immunotherapy Innovative solution provides cell-based tools for translational research and development SANTA CLARA, Calif., May 7, 2019 Agilent Technologies Inc. (NYSE: A) announces a unified portfolio of products for immunotherapy researchers. The innovative solution will showcase at Immunology 2019, the 103rd Annual Meeting of the American Association of Immunologists... Read more